| abstract |
The present invention relates to novel compounds of formula (I) which show high affinity and activity towards the a2d subunit of voltage-gated calcium channels (VOCC) or dual activity towards the a2d subunit of voltage-gated calcium channels (VOCC) and the noradrenaline transporter (NET). The invention also relates to the process for the preparation of said compounds, as well as the compositions comprising them, and to their use as a medicine.n n(I) |